Digoxin increases mortality among women with congestive heart failure

Related Experiment Video

Updated: Sep 27, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Sharon See1, Patricio Bruno

  • 1St. John's University, College of Pharmacy and Allied Health Professions, Jamaica, NY, USA. sees@stjohns.edu

The Journal of Family Practice
|February 15, 2003
PubMed

Insights

Digoxin may increase mortality in women with congestive heart failure (CHF). Alternative therapies offer proven benefits, suggesting a need to reconsider digoxin use in women with reduced ejection fractions.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Digoxin is a medication used to treat heart failure.
  • Studies suggest digoxin may increase mortality in women with congestive heart failure (CHF) compared to men.
  • The clinical significance of this gender difference is unclear, as gender is a nonmodifiable risk factor.

Discussion:

  • A potential harm signal exists for women treated with digoxin compared to placebo.
  • Established CHF therapies like ACE inhibitors, beta-blockers, and spironolactone have demonstrated clear benefits.
  • These findings warrant a re-evaluation of digoxin's role in managing CHF in women.

Key Insights:

  • Digoxin's use in women with CHF warrants careful consideration due to potential increased mortality.
  • Alternative CHF treatments with proven efficacy should be prioritized.
  • Gender-specific effects of digoxin in CHF require further investigation.

Outlook:

  • Future research should explore the mechanisms behind digoxin's potential differential effects in women.
  • Clinical guidelines may need updating regarding digoxin use in female CHF patients.
  • Further studies are needed to confirm the observed safety concerns and explore alternative treatment strategies.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...